EPISODE · Nov 11, 2020 · 6 MIN
Agentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company’s Growth Strategy with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Agentix Biopharma (AGTX)(“the Company”), a biotechnology company focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). CEO of the Company, Rudy Mazzocchi, joined Stock Day host Everett Jolly. Read Full Press Release:https://stockdaymedia.com/agentix-biopharma-ceo-rudy-mazzocchi-discusses-the-companys-growth-strategy-with-the-stock-day-podcast-agtx-november-11-2020/ Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
Ready to play
Agentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company’s Growth Strategy with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.